Orthocell (ASX $OCC) has been featured in a story titled “WA training for the heavyweight fight”, published in The West Australian’s Business section this weekend.
VIDEO | Proactive Investors – March 2023
Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had secured Device Technologies as the exclusive distribution partner for Remplir™ in the Australian marketplace.
Finding the Front Podcast | February 2022
This week, Orthocell’s CEO and MD, Paul Anderson, joined Tim Banfield on Euroz Hartley’s Finding the Front Podcast.
Remplir™ Gains Australian Reimbursement
Orthocell was featured in the widely read column, Dr Boreham’s Crucible, written by respected small cap analyst and business journalist, Tim Boreham.
Stockhead Investor Guide | September 2022
Orthocell was featured in the widely read column, Dr Boreham’s Crucible, written by respected small cap analyst and business journalist, Tim Boreham.
Ortho-ATI™ Shoulder Tendon Study Update
Orthocell has today shared positive results from the crossover extension arm of our randomised clinical trial examining the performance of our OrthoATI™ therapy in the treatment of rotator cuff tendon injuries, compared to a steroid injection.
First orders for dental and nerve products
Orthocell has now received first purchase orders for our flagship collagen medical device products Striate+™ and Remplir, via our valued distribution partners.
Beyond the Medicine Cabinet Podcast | September 2022
Orthocell’s CEO and Managing Director Paul Anderson has featured on Beyond The Medicine Cabinet podcast to talk about regenerative nerve repair, and how Orthocell’s Remplir™ collagen nerve wrap is revolutionising surgery for patients with peripheral nerve injuries.
VIDEO | Proactive Investors – September 2022
Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had secured Device Technologies as the exclusive distribution partner for Remplir™ in the Australian marketplace.
Orthocell appoints Device Technologies as distributor of its nerve repair device in Aus, NZ
Orthocell’s distribution deal with Device Technologies has been featured in The West Australian, in this news article by business reporter Cheyanne Enciso.